This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Pharma Mar, S.a.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Pilar Lardelli: Innovator in Cancer Treatment
Introduction
Pilar Lardelli is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer treatment, particularly in the development of innovative methods for managing small cell lung cancer (SCLC). With a total of 5 patents, her work has the potential to improve the lives of many patients.
Latest Patents
Lardelli's latest patents include a method of treating SCLC and managing thrombocytopenia. This invention provides methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin through intravenous infusion. It also outlines the administration of lurbinectedin in combination with other anticancer drugs, particularly topoisomerase inhibitors. Furthermore, the invention addresses the administration of lurbinectedin alongside anti-emetic agents to effectively control symptoms related to nausea and vomiting. It emphasizes reduced lurbinectedin dosages to achieve safer administration and an increase in the number of treatment cycles. Additionally, stable lyophilized formulations of lurbinectedin are provided. Another patent focuses on a method of treating SCLC and managing neutropenia, which shares similar therapeutic approaches and benefits.
Career Highlights
Pilar Lardelli is associated with Pharma Mar, S.A., a company known for its commitment to developing innovative therapies for cancer treatment. Her work at Pharma Mar has positioned her as a key player in the pharmaceutical industry, contributing to advancements in cancer care.
Collaborations
Lardelli collaborates with notable colleagues, including Carmen Kahatt and José María Fernandez. These partnerships enhance the research and development efforts within her field, fostering innovation and progress.
Conclusion
Pilar Lardelli's contributions to cancer treatment through her patents and work at Pharma Mar highlight her dedication to improving patient outcomes. Her innovative methods and collaborations continue to pave the way for advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile